Earlier this week, Joseph Damond joined BIO as Senior Vice President of International Affairs. He brings extensive experience in international affairs, trade and economics, most recently serving as Vice President of International Government Relations at Pfizer, Inc. He previously served as Deputy Vice President for International Affairs at PhRMA and as the Deputy Assistant for the Asia-Pacific region in the Office of the U.S. Trade Representative.
Joe will spearhead BIO’s international trade policy and help lead the organization’s advocacy efforts for global market access, intellectual property and regulatory issues. Over the past few years, BIO has significantly expanded its international portfolio, launching partnering meetings in China and India and increasing its advocacy efforts on global policy issues critical to the industry.
One of Joe’s first actions was to issue a statement in support of the enactment of the Korea-U.S. Free Trade Agreement (KORUS):
“America’s biotechnology industry benefits from trade agreements such as the KORUS FTA, which contains strong intellectual property provisions and sections which level the playing field in Korea for American companies that are developing new treatments and cures for disease as well as other innovative biotechnology products. The U.S. biotechnology industry is one of our most dynamic and globally competitive sectors but can face obstacles in foreign markets. Agreements such as the KORUS FTA help to eliminate those obstacles and allow the industry to remain competitive globally. We support prompt consideration and enactment of this agreement by Congress followed by rapid implementation of its provisions by Korea so that our companies can expand access to innovative therapies and other biotech products abroad while increasing the number of high-wage, high-skill jobs in the U.S.”